Amarin announced that its supplemental new drug application for Vascepa has been accepted for filing and granted Priority Review designation by the FDA; civil rights groups ask a federal court to strike down an HHS "conscience" rule that may limit services covered by providers and payers that violate religious or moral beliefs; US Representive Seth Moulton, D-Massachusetts, unveils a new military mental health proposal.
Amarin announced that its supplemental new drug application (sNDA) for Vascepa has been accepted for filing and granted Priority Review designation by the FDA, according to a statement from the company. The Prescription Drug User Fee Act goal date assigned by the FDA for the sNDA is September 28, 2019, which is 4 months earlier than the expected 10-month standard review for applications due to its Priority Review designation. The sNDA was based on findings from the REDUCE-IT cardiovascular outcomes study, and if the indication is approved, Vascepa will be the first drug indicated to reduce residual cardiovascular risk in patients with statin-managed low-density lipoprotein cholesterol that have persistent elevated triglycerides.
Lamba Legal and other civil rights groups have asked a federal court to strike down an HHS “conscience” rule that may create situations where healthcare providers, insurers, and other payers could refuse to cover services that they claim violate their religious or moral beliefs, The Washington Post reported. The lawsuit was filed yesterday in the United States District Court for the Northern District of California and claims the policy, published May 21, is unconstitutional and exceeds HHS’ statutory authority. The plaintiffs emphasized that while transgender individuals may be most vulnerable to discrimination under the rule, it would affect all Americans. President Trump personally announced the rule during a speech before faith leaders who claim protections are necessary due to ineffectual enforcement of existing statutes that protect such decisions.
Representative Seth Moulton, D-Massachusetts, will introduce a plan Tuesday to expand military mental health services, POLITICO reported. While the policy proposal has not yet been set in legislation, it would require mental health checkups in addition to annual physical exams for veterans and active-duty servicemen and mandate a counseling session for all troops within 2 weeks of their return from combat deployment. It would also provide funds for yearly mental health screening for every high school student in the country.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More